Product
Induction Chemo-Immunotherapy
1 clinical trial
1 indication
Indication
Lung CancerClinical trial
A Prospective Phase II Controlled Study to Evaluate the Impact of Thymosin Alpha 1 on the Completion Rate of Consolidation Immunotherapy After Radical Radiochemotherapy for Locally Advanced Non-Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2025-08-01